AU2021902408A0 - Self-cleaving polyproteins and uses thereof - Google Patents

Self-cleaving polyproteins and uses thereof

Info

Publication number
AU2021902408A0
AU2021902408A0 AU2021902408A AU2021902408A AU2021902408A0 AU 2021902408 A0 AU2021902408 A0 AU 2021902408A0 AU 2021902408 A AU2021902408 A AU 2021902408A AU 2021902408 A AU2021902408 A AU 2021902408A AU 2021902408 A0 AU2021902408 A0 AU 2021902408A0
Authority
AU
Australia
Prior art keywords
polyproteins
cleaving
self
cleaving polyproteins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2021902408A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Melbourne
Original Assignee
University of Melbourne
Filing date
Publication date
Application filed by University of Melbourne filed Critical University of Melbourne
Publication of AU2021902408A0 publication Critical patent/AU2021902408A0/en
Priority to AU2022321056A priority Critical patent/AU2022321056A1/en
Priority to PCT/AU2022/050844 priority patent/WO2023010177A1/en
Abandoned legal-status Critical Current

Links

AU2021902408A 2021-08-04 2021-08-04 Self-cleaving polyproteins and uses thereof Abandoned AU2021902408A0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AU2022321056A AU2022321056A1 (en) 2021-08-04 2022-08-04 Self-cleaving polyproteins and uses thereof
PCT/AU2022/050844 WO2023010177A1 (en) 2021-08-04 2022-08-04 Self-cleaving polyproteins and uses thereof

Publications (1)

Publication Number Publication Date
AU2021902408A0 true AU2021902408A0 (en) 2021-08-19

Family

ID=

Similar Documents

Publication Publication Date Title
EP3759143A4 (en) Anti-tigit antibodies and uses thereof
EP3740224A4 (en) Anti-lilrb antibodies and uses thereof
EP3762030A4 (en) Anti-cd73 antibodies and uses thereof
EP3752612A4 (en) Modified compounds and uses thereof
EP3838289A4 (en) Anti-tigit antibody and uses thereof
EP3805223A4 (en) 2,3-dihydro-1h-pyrrolizine-7-formamide derivative and application thereof
EP3918323A4 (en) Anti-gal3 antibodies and uses thereof
EP3875484A4 (en) Cll1-targeting antibody and application thereof
EP3997127A4 (en) Dll3-targeting antibodies and uses thereof
EP3735427A4 (en) Anti-mct1 antibodies and uses thereof
EP4037670A4 (en) 5-fluoronicotinamide derivatives and uses thereof
EP3790586A4 (en) Anti-dll3 antibodies and uses thereof
EP3999545A4 (en) Anti-cd73 antibody and application thereof
EP4047019A4 (en) Anti-tslp antibody and uses thereof
EP3861118A4 (en) Modified oligomeric compounds and uses thereof
EP3843736A4 (en) Isoquinoline-steroid conjugates and uses thereof
EP3962954A4 (en) Anti-galectin-9 antibodies and uses thereof
EP3768317A4 (en) Anti-il-27 antibodies and uses thereof
EP3845532A4 (en) Quinolino-pyrrolidin-2-one derivative and application thereof
EP4071172A4 (en) Anti-lilrb1 antibody and uses thereof
EP4013428A4 (en) Modified oligomeric compounds and uses thereof
EP4025609A4 (en) Anti-steap1 antibodies and uses thereof
EP4001308A4 (en) Anti-tigit antibodies and application thereof
EP3968974A4 (en) Cannabinoids and uses thereof
EP3894440A4 (en) Anti-il-27 antibodies and uses thereof